(Q36392269)

English

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

6

object named as

Pierre Miossec

0 references

author name string

Hubert Marotte

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Beatrice Pallot-Prades

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Laurent Grange

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Philippe Gaudin

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Christian Alexandre

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R61

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

https://scigraph.springernature.com/pub.10.1186/ar2219

0 references

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

30 September 2017

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

28 June 2018

The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

21 September 2018

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

21 September 2018

Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2206336

21 September 2018

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17597527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/17597527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of natural and surgical menopause on the secretion of cytokines from human blood monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17597527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17597527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/17597527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products

1 reference

https://pubmed.ncbi.nlm.nih.gov/17597527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

release_mynodhkp2rg6hc4y7xkkxpxzva

1 reference

https://api.fatcat.wiki/v0/release/mynodhkp2rg6hc4y7xkkxpxzva

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36392269&oldid=1837966877"